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A Call for Change in CE 
Within a healthcare team, every professional contributes in 
different ways.  As a result, physicians, nurses, and 
pharmacists, although aligned with the goal of serving 
patients, have different learning needs.  At the same time, 
this learning is intended to be an integral part of how all 
practitioners provide the most up-to-date care to their 
patients [1].  In 2009, the Institute of Medicine (IOM) 
identified an urgent need to reform the continuing education 
(CE) system for health care professionals [2].  This report 
identifies specific concerns about our current system that 
include a poorly constructed vision, a lack of inter-
professional approach to education delivery, and general 
concerns about regulation and evaluation of continuing 
education [2].  The IOM creates a challenging mission for 
healthcare professionals and regulatory bodies, based on 
their recommendations.   
 
Charged with this information, health professions are 
examining better ways to design, deliver, and evaluate the 
learning of their peers with the goal of enhancing the life-long 
learning process [2].  The IOM report suggests endorsing and 
encouraging the creation of continuing professional 
development (CPD) programs for healthcare professionals.  
CPD is a lifelong-learning method where healthcare 
professionals identify and implement individual goals [1, 2-7].  
Following the goal-making process, a pharmacist also 
identifies the path they will take to get there.  Finally, once 
the goal has been achieved, the practitioner reflects on the 
value of their journey.  A portion of the CPD documentation is 
then shared with a regulatory board for credit approval.  As 
CPD gains momentum, Boards of Pharmacy have begun to 
evaluate the role of this type of learning in the education of 
pharmacists.  This commentary aims to describe the value of 
CPD in better assuring continued competency and the 
challenges and considerations that must be addressed by 
Boards of Pharmacy prior to CPD implementation.  
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The Board of Pharmacy Role 
Regulatory agencies are charged by legislation to protect the 
public. As an example, in Minnesota Statue 151, the role of a 
regulatory organization is outlined.  Among many 
responsibilities that include inspecting pharmacies and 
regulating the sale of medications, the Minnesota Board of 
Pharmacy (MBoP) is charged with granting licensure and 
ongoing competency assessment [8].  A component of this is 
summarized in Minnesota Statute 151.13, which grants the 
organization the authority to gather information about 
continuing education and how it is delivered [9].  In addition, 
the MBoP mission statement includes specific reference to 
overseeing and guaranteeing continued education of the 
professionals with the privilege to practice in the state [10].  
Continuing education is a learning process intended for all 
pharmacy practitioners with the goal of maintaining current 
standards of practice and encouraging continual problem-
solving skill development [11].  Throughout the country, 
regardless of the depth or breadth of each states’ Pharmacy 
Practice Act, there is a Board of Pharmacy charged with 
similar responsibilities as those cited above.  Without a Board 
of Pharmacy to regulate and guarantee competency, would 
all pharmacists be inspired to keep up-to-date through 
continual education?  There is no way to answer this 
rhetorical question, but the system we have currently 
provides some assurance to the public that this expectation is 
met by every pharmacist in the state.   
 
From CE to CPD 
In 1965, Florida became the first state to require CE for 
pharmacists [5,12].  No less than ten years later, the National 
Association of Boards of Pharmacy created a formal 
resolution requiring continued learning for all pharmacists 
[5,12].   But even thirty-five years ago, the system for CE 
credit was in question.  It was Knox, in 1975, that identified a 
need for pharmacists to reform their continuing education 
system in such a way that the focus is truly on enhancing 
patient care [13].  His suggestions included the creation of a 
system that encouraged pharmacists to identify needs, 
execute a learning plan, and reflect upon completion- not 
unlike what CPD is designed to accomplish today [13].  With 
CPD, regulatory agencies are able to better appreciate a 
pharmacist’s learning needs and how a pharmacist has 
maintained their competency during any given time period.  
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meet their obligation to protect the public and to ensure 
competency.  As a result, Board of Pharmacy involvement 
with the evolution of CPD is vital.   
 
The Current Status of CPD 
Throughout the past decade, a number of countries outside 
the United States (US), as well as several states have begun to 
recognize CPD for pharmacists [6].  In the traditional CE 
delivery, material is presented in an online or live classroom 
format.  The learning consists of listening and reading, then 
applying the information to an assessment, often in the form 
of a multiple-choice exam.  CPD asks more of the pharmacist.  
He or she must spend time identifying areas of interest within 
their career.  More importantly, they must plan a direction 
through which their learning will take shape.  In this model, 
pharmacists have more control over what they learn and can 
expand their “classroom” to include many settings that are 
not assigned Board of Pharmacy credit in the current CE 
system.  Since its introduction, CPD has been supported by a 
number of prominent national pharmacy organizations, 
including Accreditation Council for Pharmacy Education, 
American Pharmacists Association, American Association of 
Colleges of Pharmacy, American Society of Health-System 
Pharmacists, Joint Commission of Pharmacy Practitioners, 
and the National Association of Boards of Pharmacy.  These 
organizations have supported CPD both as a suggested 
method of improving the continuing education system as well 
as a necessary method to help keep pharmacists engaged [11, 
14-18].   
 
A growing body of evidence is being published on the 
potential role CPD might play in our CE system.  As an 
example, following their study with 57 pharmacists in five 
states, Dopp, et al concluded that when pharmacists are 
supported correctly, CPD can serve an important role in their 
lifelong learning [5].  At the same time, after conducting a 
study with 42 pharmacists from Ontario, Canada, Austin et al 
reported that pharmacists perceived CPD as frustrating [3].   
Specifically, pharmacists in this study felt uncomfortable with 
the various steps of CPD, especially their ability to identify 
areas of potential deficiency [3].  This article suggests that 
more support is needed if pharmacists are to successfully 
utilize CPD and maximize its potential [3]. 
 
Considerations 
Regulatory bodies will encounter challenges when 
implementing systems like CPD.  As such, there are a number 
of considerations Boards of Pharmacy must address when 
deciding if and how to implement CPD as an option for their 
pharmacists.  The first consideration is assigning value.   Prior 
to CPD, the currency to evaluate learning value has been 
hours.  Although this measurement is objective, it is not 
perfect.  Does an hour of lecture or online reading produce 1 
hour of actual learning?  If a transition to CPD Is made, what 
is the comparable value of 1 hour of CPD versus 1 hour of 
traditional CE?  If hours aren’t the currency, what is?  These 
questions are challenging to answer, but important 
considerations for a regulatory body.  
The second consideration is acceptance of CPD by 
pharmacists.  Several articles have shown a benefit perceived 
by pharmacists using this method of learning [1,5-7].  Several 
other articles have indicated there are barriers currently 
preventing CPD from becoming the standard [3,4].  The major 
concern presented is recognition and understanding of CPD.  
Pharmacists are willing to work with CPD, but some do not 
fully understand its role and function.  In Ontario, where CPD 
has become a standard of learning, major challenges have 
been education and acceptance.  These barriers are being 
addressed in a number of ways, including providing 
pharmacists with the freedom to create their own 
documentation structure, creating a website to help guide 
pharmacists, and patience and persistence, as the number of 
pharmacists familiar with this learning method increases 
annually [S Winkelbauer, personal communication, August 
19, 2010].  As a result of the regulatory board’s leadership, 
CPD has not only become a standard of lifelong learning for 
pharmacists in Ontario, but also has been designed and 
developed by the organization responsible for its 
enforcement.   
 
 A final consideration is cost.  Although there are few 
published studies indicating an estimated cost for CPD, there 
are several potential costs that need to be evaluated when 
considering CPD implementation.  The first is training.  In 
order to successfully implement CPD, a group of pharmacists 
must be trained to train others in using CPD.  If the state 
chooses to create a documentation system, this may also add 
costs.  Some states with CPD have opted to use their State 
Board of Pharmacy website to create a documentation 
system, in an effort to curb this potentially crippling expense.  
Finally, there are costs associated with the time and expertise 
required to review the documentation once it has been 
submitted for Board of Pharmacy approval.  In North 
Carolina, where a pilot project led to the creation of a formal 
option of CPD offered to pharmacists, several strategies have 
kept the cost to a minimum.  The pharmacists who train 
others to use CPD do so with voluntary time.  Also, the CPD 
training for pharmacists is a 3-hour ACPE-accredited CE with a 
fee for those who attend [T. Tofade, personal communication 
August 24, 2010].  This revenue helps to offset additional 
costs associated with CPD.   Using these resources, the North 
Carolina Board of Pharmacy has been able to keep their cost 
within a range that makes this project feasible. 
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In Closing 
As health care professions begin to expand their definitions of 
continuing education, there is an increased emphasis being 
placed on the use of CPD [3,6].  Regulatory boards are 
beginning to assess the role of goal-based learning, and as a 
result, they are trying to seek answers about the value, 
acceptance and cost of CPD.   The Board of Pharmacy has an 
obligation to the public to ensure all pharmacists are 
competent to practice.  In the coming years, CPD may prove 
to be a vital piece of that life-long learning assessment. 
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